Shay Capital’s Elevance Health ELV Stock Holding History

Shay Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,000	Closed	-$878K	–	541
2026 Q1	$878K	Sell	3,000 -3,000	-50%	-$986K	0.07%	186
2025 Q4	$2.1M	Sell	6,000 -10,250	-63%	-$3.46M	0.22%	108
2025 Q3	$5.25M	Buy	+16,250	New	+$5.05M	0.46%	55
2025 Q2	–	Sell	-4,000	Closed	-$1.74M	–	358
2025 Q1	$1.74M	Buy	+4,000	New	+$1.61M	0.25%	64
2023 Q2	–	Sell	-1,250	Closed	-$575K	–	455
2023 Q1	$575K	Buy	+1,250	New	+$595K	0.11%	152
2022 Q4	–	Sell	-4,000	Closed	-$1.82M	–	316
2022 Q3	$1.82M	Sell	4,000 -5,000	-56%	-$2.39M	0.39%	42
2022 Q2	$4.34M	Buy	9,000 +3,500	+64%	+$1.73M	0.87%	22
2022 Q1	$2.7M	Buy	5,500 +4,500	+450%	+$2.06M	0.35%	36
2021 Q4	$464K	Buy	+1,000	New	+$421K	0.08%	193

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Shay Capital's ELV Position: Q2 2026 in Review

Shay Capital sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 3,000 shares — an estimated $878K sold.

Shay Capital first reported a position in ELV in Q4 2021 and held it in 9 quarters. The position peaked at $5.25M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Shay Capital reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
Shay Capital sold 3,000 Elevance Health shares in Q2 2026, an estimated $878K.
Shay Capital first reported a position in Elevance Health in Q4 2021 and held it in 9 quarters.
Shay Capital's Elevance Health position peaked at $5.25M in Q3 2025.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.